Sun Pharma’s Dilip Shanghvi and Uday Kotak re-entered the list this year, replacing Kumar Mangalam Birla of Aditya Birla Group and Jay Chaudhary of Zscaler, according to the study based on estimates till August 30, 2022.
Valuations turn attractive as markets look beyond uncertainty: A Balasubramanian
Amidst geopolitical uncertainty, market expert A Balasubramanian suggests the worst may be nearing an end, with improving macro signals and reasonable valuations in Indian equities.